Literature DB >> 2665468

New concepts in the pathophysiology of acute myocardial infarction.

C J Pepine1.   

Abstract

Recent findings concerning the pathophysiology of acute myocardial infarction are reviewed and related to the potential for myocardial salvage. The myocardial infarction process can be divided into 2 phases, an early evolving phase (the first 6 hours) and a later convalescent phase. An evolving infarction is associated with an occluded coronary artery; in most cases, a thrombotic occlusion occurs. The human coronary artery normally has an intact endothelium, which has protective vasodilatory and antiplatelet-aggregating effects that are lost when the endothelium is damaged. The endothelium is exquisitely sensitive to trauma and can be damaged by high shear stress produced by narrowing of the coronary arteries that is not associated with reduced coronary blood flow. In addition, during this acute endothelial damage, monocellular infiltration of the coronary arteries has the potential to release factors that may cause platelet aggregation, enhance blood coagulation, attract other white blood cells or exert other effects on the coronary tree. Myocardial damage occurring in the early evolving stage is usually responsive to treatment that either restores myocardial oxygen supply or reduces myocardial oxygen demand. However, coronary events occurring after the first 6 hours usually are not responsive to such treatment. Certain clinical variables may shorten or extend the time period within which damaged myocardium can be saved. The findings suggest important approaches for intervention to modify the acute phase.

Entities:  

Mesh:

Year:  1989        PMID: 2665468     DOI: 10.1016/s0002-9149(89)80002-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  The effects of Radix Ginseng rubra on cAMP of experimental ischemic myocardium in rats.

Authors:  Z Liu; J Zhang; X Ouyang; X Liu; X Guan
Journal:  J Tongji Med Univ       Date:  1999

2.  Effects of propranolol on beta-adrenergic receptor of experimental acute myocardial infarction in rats.

Authors:  Z Liu; X Liu; J Zhang; X Ouyang; X Guan
Journal:  J Tongji Med Univ       Date:  1997

Review 3.  3D bioprinting for cardiovascular regeneration and pharmacology.

Authors:  Haitao Cui; Shida Miao; Timothy Esworthy; Xuan Zhou; Se-Jun Lee; Chengyu Liu; Zu-Xi Yu; John P Fisher; Muhammad Mohiuddin; Lijie Grace Zhang
Journal:  Adv Drug Deliv Rev       Date:  2018-07-24       Impact factor: 15.470

Review 4.  The pathophysiology and epidemiology of myocardial infarction. A review.

Authors:  J Gill
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Lethal myocardial infarction subsequent to compression of the left anterior descending coronary artery induced by traumatic hematoma.

Authors:  S Jensen; I B Kristensen; B O Kristensen
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

6.  Beneficial effects of bradykinin on porcine ischemic myocardium.

Authors:  R A Tio; T J Tobé; K J Bel; C D de Langen; W H van Gilst; H Wesseling
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

7.  Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.

Authors:  Jing Zhang; Lelin Huang; Xing Shi; Liu Yang; Fuzhou Hua; Jianyong Ma; Wengen Zhu; Xiao Liu; Rui Xuan; Yunfeng Shen; Jianping Liu; Xiaoyang Lai; Peng Yu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.